Cancer Genetic Test Proteo
If you find it early, 5-year survival rates are over 95%!
Do you know? The fact is that after most “Cancers” were found early, it has become completely cured.
If recurrence is not seen for 5 years after treatment is completed, it is commonly expressed as a “Complete cure”, but if you look at the data released by the National Cancer Center Association,
＜Case of those who found “cancer” on stage I and performed surgery＞
The 5-year relative survival rate is 95.4% for all “Cancers” and 100% for “Stomach cancer”, “Rectal cancer”, “breast cancer”, etc.
However, when the discovery is delayed to stage IV, the 5-year relative survival rate drops sharply, for example, it becomes 16.9% in “Stomach cancer”.
The most important thing in treating “Cancer” is to discover “Cancer” earlier than anything else.
The targets are solid cancers such as lung cancer, breast cancer, stomach cancer, liver cancer, colon cancer, tongue cancer, thyroid cancer, kidney cancer, prostate cancer, uterine cancer, and ovarian cancer.
When cancer occurs in the body, cancer related substances will dissolve in the blood. We measure cancer-related substances in the blood adsorbed on the test chip using a fluorescence microscope and judge the risk of cancer with three levels of A, B, and C.
The blood used for the examination is very small (30 microliters) and is not affected by meals etc, so it has a light physical burden and is a safe inspection method.
Furthermore, since the measured values appear with clear differences in this test, the judgment is easy, and the possibility of erroneous judgment is also unlimitedly low. Besides the early detection of cancer, it is also useful for progress risk, recurrence / metastasis risk, risk of treatment effect, etc.
Cancer related substances: Protein complexes containing DNA (nucleosome presumption) react with new substances formed on Proteo chip, adsorbed by silver peroxide mesocrystals. By looking at this with a fluorescence microscope, it is possible to detect also cancer of stage 0 in the very early stage, and it is possible to identify and examine multiple cancers by one examination.
It is very difficult to distinguish between benign and malignant tumors, and a high sensitivity and high specificity test method is required.
Because the crystals of free-release cancer-related substances are substances derived from apoptosis-related cells, the amount contained in benign diseases (people who are not cancerous) and benign tumors is small, and there are many features to be included in specific cancer.
Compared with benign diseases and benign tumors, fluorescence is more common in malignant tumors.
Flow of inspection
1. Collect a small amount of blood from your fingertip.
2. It will be sent to a special inspection organization and inspected. The results of the test by Proteo Ⓡ are digitized, the risk judgment is made, and an inspection result report will be sent to the doctor.
3. Based on the inspection result report, the doctor will explain the results. Based on the results, we will propose additional guidance and future treatment.
Do I need to refrain from eating or drinking before taking blood?
Tests with Proteo® are not affected by meals and drinks, so there is no need for diet restrictions. However, please refrain from excessive alcohol intake.
Can I use health insurance?
Health insurance is not applicable because it will be treated as free medical treatment.